Manor Moshe (CIK 0001623532)

Latest company ownership

Shares held
1,300,000
Last filed at
Sep 14, 2018
Confidence Score
50.0
2025Q4
Confidence Score History
2017Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
May 16, 2017 May 16, 2017 Protalix BioTherapeutics, Inc. CEO Buy 91.3 +50,000 100.00% ✗ $40.5K